Literature DB >> 33338684

Exclusive enteral nutrition induced sustained changes in the microbiota and improved inflammatory bowel disease in a pediatric patient with chronic granulomatous disease.

Emilia Liana Falcone1, Yu Han2, Samantha Kreuzburg3, Theo Heller4, Joseph A Church5, Caroline Grou6, Virginie Calderon6, Poorani Subramanian7, Clayton Deming8, Sean Conlan8, Julia A Segre8, Steven M Holland3, Christa S Zerbe3.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 33338684      PMCID: PMC7875062          DOI: 10.1016/j.jaip.2020.12.014

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


× No keyword cloud information.
  9 in total

Review 1.  Gastrointestinal Complications in Chronic Granulomatous Disease.

Authors:  E Liana Falcone; Steven M Holland
Journal:  Methods Mol Biol       Date:  2019

2.  Resveratrol modulates the gut microbiota to prevent murine colitis development through induction of Tregs and suppression of Th17 cells.

Authors:  Haider Rasheed Alrafas; Philip B Busbee; Mitzi Nagarkatti; Prakash S Nagarkatti
Journal:  J Leukoc Biol       Date:  2019-03-21       Impact factor: 4.962

Review 3.  Faecalibacterium prausnitzii and human intestinal health.

Authors:  S Miquel; R Martín; O Rossi; L G Bermúdez-Humarán; J M Chatel; H Sokol; M Thomas; J M Wells; P Langella
Journal:  Curr Opin Microbiol       Date:  2013-07-03       Impact factor: 7.934

4.  Residual NADPH oxidase and survival in chronic granulomatous disease.

Authors:  Douglas B Kuhns; W Gregory Alvord; Theo Heller; Jordan J Feld; Kristen M Pike; Beatriz E Marciano; Gulbu Uzel; Suk See DeRavin; Debra A Long Priel; Benjamin P Soule; Kol A Zarember; Harry L Malech; Steven M Holland; John I Gallin
Journal:  N Engl J Med       Date:  2010-12-30       Impact factor: 91.245

Review 5.  Inflammatory bowel disease.

Authors:  Clara Abraham; Judy H Cho
Journal:  N Engl J Med       Date:  2009-11-19       Impact factor: 91.245

6.  Gastrointestinal involvement in chronic granulomatous disease.

Authors:  Beatriz E Marciano; Sergio D Rosenzweig; David E Kleiner; Victoria L Anderson; Dirk N Darnell; Sandra Anaya-O'Brien; Dianne M Hilligoss; Harry L Malech; John I Gallin; Steven M Holland
Journal:  Pediatrics       Date:  2004-08       Impact factor: 7.124

Review 7.  Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases.

Authors:  Ramnik J Xavier; Curtis Huttenhower; Jason Lloyd-Price; Cesar Arze; Ashwin N Ananthakrishnan; Melanie Schirmer; Julian Avila-Pacheco; Tiffany W Poon; Elizabeth Andrews; Nadim J Ajami; Kevin S Bonham; Colin J Brislawn; David Casero; Holly Courtney; Antonio Gonzalez; Thomas G Graeber; A Brantley Hall; Kathleen Lake; Carol J Landers; Himel Mallick; Damian R Plichta; Mahadev Prasad; Gholamali Rahnavard; Jenny Sauk; Dmitry Shungin; Yoshiki Vázquez-Baeza; Richard A White; Jonathan Braun; Lee A Denson; Janet K Jansson; Rob Knight; Subra Kugathasan; Dermot P B McGovern; Joseph F Petrosino; Thaddeus S Stappenbeck; Harland S Winter; Clary B Clish; Eric A Franzosa; Hera Vlamakis
Journal:  Nature       Date:  2019-05-29       Impact factor: 49.962

8.  Extensive Modulation of the Fecal Metagenome in Children With Crohn's Disease During Exclusive Enteral Nutrition.

Authors:  Christopher Quince; Umer Zeeshan Ijaz; Nick Loman; A Murat Eren; Delphine Saulnier; Julie Russell; Sarah J Haig; Szymon T Calus; Joshua Quick; Andrew Barclay; Martin Bertz; Michael Blaut; Richard Hansen; Paraic McGrogan; Richard K Russell; Christine A Edwards; Konstantinos Gerasimidis
Journal:  Am J Gastroenterol       Date:  2015-11-03       Impact factor: 10.864

Review 9.  Exclusive enteral nutrition versus corticosteroids for treatment of pediatric Crohn's disease: a meta-analysis.

Authors:  Yu Yu; Kang-Chen Chen; Jie Chen
Journal:  World J Pediatr       Date:  2019-01-21       Impact factor: 2.764

  9 in total
  1 in total

Review 1.  Inborn errors of immunity and related microbiome.

Authors:  Raja Hazime; Fatima-Ezzohra Eddehbi; Saad El Mojadili; Nadia Lakhouaja; Ikram Souli; Abdelmouïne Salami; Bouchra M'Raouni; Imane Brahim; Mohamed Oujidi; Morad Guennouni; Ahmed Aziz Bousfiha; Brahim Admou
Journal:  Front Immunol       Date:  2022-09-13       Impact factor: 8.786

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.